📢💊 EMA starts a #RollingReview of #molnupiravir, an oral antiviral medicine for the treatment of #COVID19 in adults. #COVID19treatment

Read more: https://t.co/M33axkADKC pic.twitter.com/pi0i5HBNhV

— EU Medicines Agency (@EMA_News) October 25, 2021